HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Abstract
The treatments and prognoses of pelvic organ carcinomas differ, depending on whether the primary tumor originated in the rectum, urinary bladder, prostate, ovary, or uterus; therefore, it is essential to diagnose pathologically the primary origin and stages of these tumors. To establish the panels of immunohistochemical markers for differential diagnosis, we reviewed 91 of the NCBI articles on these topics and found that the results correlated closely with those of the public protein database, the Human Protein Atlas. The results revealed the panels of immunohistochemical markers for the differential diagnosis of rectal adenocarcinoma, in which [+] designates positivity in rectal adenocarcinoma and [-] designates negativity in rectal adenocarcinoma: from bladder adenocarcinoma, CDX2[+], VIL1[+], KRT7[-], THBD[-] and UPK3A[-]; from prostate adenocarcinoma, CDX2[+], VIL1[+], CEACAM5[+], KLK3(PSA)[-], ACPP(PAP)[-] and SLC45A3(prostein)[-]; and from ovarian mucinous adenocarcinoma, CEACAM5[+], VIL1[+], CDX2[+], KRT7[-] and MUC5AC[-]. The panels of markers distinguishing ovarian serous adenocarcinoma, cervical carcinoma, and endometrial adenocarcinoma were also represented. Such a comprehensive review on the differential diagnosis of carcinomas of pelvic organs has not been reported before. Thus, much information has been accumulated in public databases to provide an invaluable resource for clinicians and researchers.
AuthorsKoh Miura, Kazuyuki Ishida, Wataru Fujibuchi, Akihiro Ito, Hitoshi Niikura, Hitoshi Ogawa, Iwao Sasaki
JournalSurgery today (Surg Today) Vol. 42 Issue 6 Pg. 515-25 (Jun 2012) ISSN: 1436-2813 [Electronic] Japan
PMID22441574 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
Topics
  • Adenocarcinoma (chemistry, genetics, secondary)
  • Biomarkers, Tumor (analysis)
  • Diagnosis, Differential
  • Endometrial Neoplasms (chemistry, genetics, pathology)
  • Female
  • Genes, Neoplasm (genetics)
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis
  • Male
  • Neoplasm Staging
  • Ovarian Neoplasms (chemistry, genetics, pathology)
  • Prostatic Neoplasms (chemistry, genetics, pathology)
  • Rectal Neoplasms (chemistry, genetics, pathology)
  • Urinary Bladder Neoplasms (chemistry, genetics, pathology)
  • Uterine Cervical Neoplasms (chemistry, genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: